MARKET

BCTXW

BCTXW

Briacell Therapeutics Corp
NASDAQ
0.0269
-0.0059
-17.99%
Closed 15:33 01/16 EST
OPEN
0.0300
PREV CLOSE
0.0328
HIGH
0.0300
LOW
0.0210
VOLUME
26.13K
TURNOVER
--
52 WEEK HIGH
0.2500
52 WEEK LOW
0.0113
MARKET CAP
--
P/E (TTM)
-0.0005
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BCTXW last week (0112-0116)?
Weekly Report · 22h ago
BRIACELL THERAPEUTICS ANNOUNCES CLOSING OF US$30 MILLION PUBLIC OFFERING
Reuters · 4d ago
US-LISTED SHARES OF BRIACELL THERAPEUTICS TUMBLE 55% AFTER CO PRICES $30 MLN PUBLIC OFFERING
Reuters · 5d ago
BRIACELL THERAPEUTICS CORP - UNITS SOLD AT $5.59 PER UNIT FOR $30 MLN GROSS PROCEEDS
Reuters · 6d ago
BriaCell Therapeutics Announces Pricing of $30 million Public Offering
Barchart · 6d ago
BriaCell Reports 11-Month Complete Lung Metastasis Resolution in Metastatic Breast Cancer Trial
Reuters · 6d ago
Weekly Report: what happened at BCTXW last week (0105-0109)?
Weekly Report · 01/12 09:00
BriaCell Therapeutics Reports Positive Phase 3 Data for Bria-IMT Regimen in Metastatic Breast Cancer
Reuters · 01/07 15:35
More
About BCTXW
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops immunotherapies to transform cancer care. The Company’s lead drug candidate, Bria-IMT, is a cell-based patented immunotherapy that stimulates a patient’s own cancer fighting cells to attack and destroy breast cancer tumors. The Company is advancing its targeted immunotherapy program by prioritizing a Phase II clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor. The Company is focused on conducting a Phase I/IIa clinical trial of Bria-IMT in a combination study with Incyte’s immune PD-1 inhibitor, retifanlimab, in advanced breast cancer. The Company is also developing Bria-OTS, an off-the-shelf personalized approach to whole cell cancer immunotherapy. The Bria-OTS immunotherapy is based on a patient’s HLA-type. Its pipeline also includes Bria-Pros, Bria-Lung, Bria-Mel and sCD80, which are in development to treat various cancers.

Webull offers Briacell Therapeutics Corp stock information, including NASDAQ: BCTXW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTXW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCTXW stock methods without spending real money on the virtual paper trading platform.